Cargando…
Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience
Reconstructive surgery following skin tumor resection can be challenging. Treatment options after removing the tumor are skin grafting, local pedicled and axial flaps, or microsurgery for complex and extensive wounds correction. Recently, the use of dermal substitutes has been extended to reconstruc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511644/ https://www.ncbi.nlm.nih.gov/pubmed/28751990 http://dx.doi.org/10.1155/2017/9805980 |
_version_ | 1783250373473992704 |
---|---|
author | Campagnari, Mariane Jafelicci, Andrea S. Carneiro, Helio A. Brechtbühl, Eduard R. Bertolli, Eduardo Duprat Neto, João P. |
author_facet | Campagnari, Mariane Jafelicci, Andrea S. Carneiro, Helio A. Brechtbühl, Eduard R. Bertolli, Eduardo Duprat Neto, João P. |
author_sort | Campagnari, Mariane |
collection | PubMed |
description | Reconstructive surgery following skin tumor resection can be challenging. Treatment options after removing the tumor are skin grafting, local pedicled and axial flaps, or microsurgery for complex and extensive wounds correction. Recently, the use of dermal substitutes has been extended to reconstructive surgery in cutaneous oncology. Objectives. To report both a single-center experience using dermal substitutes in reconstructive surgery for skin malignancies and reconstructive surgery's outcomes. Methods and Results. Among thirteen patients, seven (53.8%) were male with mean age of 62.6 years. Regarding diagnosis, there were five cases (38.5%) of basal cell carcinoma (BCC), two (15.4%) of melanoma in situ, two (15.4%) of dermatofibrosarcoma protuberans, one (7.7%) of squamous cell carcinoma (SCC), one (7.7%) of angiosarcoma, and one (7.7%) of eccrine carcinoma (EC). The most common site of injury was scalp (53.8%) and lower limbs (23.1%). Seven (53.8%) patients used NPWT and six (46.2%) patients underwent Brown's dressing. The most frequent complication of the first stage was wound contamination (38.5%). Average time to second-stage skin grafting was 43.9 days. Three (23%) patients developed tumor recurrence and one died. Conclusions. Use of dermal substitutes in oncology can be an option for reconstruction after extended resections, providing good aesthetical and functional results. |
format | Online Article Text |
id | pubmed-5511644 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-55116442017-07-27 Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience Campagnari, Mariane Jafelicci, Andrea S. Carneiro, Helio A. Brechtbühl, Eduard R. Bertolli, Eduardo Duprat Neto, João P. Int J Surg Oncol Research Article Reconstructive surgery following skin tumor resection can be challenging. Treatment options after removing the tumor are skin grafting, local pedicled and axial flaps, or microsurgery for complex and extensive wounds correction. Recently, the use of dermal substitutes has been extended to reconstructive surgery in cutaneous oncology. Objectives. To report both a single-center experience using dermal substitutes in reconstructive surgery for skin malignancies and reconstructive surgery's outcomes. Methods and Results. Among thirteen patients, seven (53.8%) were male with mean age of 62.6 years. Regarding diagnosis, there were five cases (38.5%) of basal cell carcinoma (BCC), two (15.4%) of melanoma in situ, two (15.4%) of dermatofibrosarcoma protuberans, one (7.7%) of squamous cell carcinoma (SCC), one (7.7%) of angiosarcoma, and one (7.7%) of eccrine carcinoma (EC). The most common site of injury was scalp (53.8%) and lower limbs (23.1%). Seven (53.8%) patients used NPWT and six (46.2%) patients underwent Brown's dressing. The most frequent complication of the first stage was wound contamination (38.5%). Average time to second-stage skin grafting was 43.9 days. Three (23%) patients developed tumor recurrence and one died. Conclusions. Use of dermal substitutes in oncology can be an option for reconstruction after extended resections, providing good aesthetical and functional results. Hindawi 2017 2017-07-02 /pmc/articles/PMC5511644/ /pubmed/28751990 http://dx.doi.org/10.1155/2017/9805980 Text en Copyright © 2017 Mariane Campagnari et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Campagnari, Mariane Jafelicci, Andrea S. Carneiro, Helio A. Brechtbühl, Eduard R. Bertolli, Eduardo Duprat Neto, João P. Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience |
title | Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience |
title_full | Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience |
title_fullStr | Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience |
title_full_unstemmed | Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience |
title_short | Dermal Substitutes Use in Reconstructive Surgery for Skin Tumors: A Single-Center Experience |
title_sort | dermal substitutes use in reconstructive surgery for skin tumors: a single-center experience |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511644/ https://www.ncbi.nlm.nih.gov/pubmed/28751990 http://dx.doi.org/10.1155/2017/9805980 |
work_keys_str_mv | AT campagnarimariane dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience AT jafelicciandreas dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience AT carneirohelioa dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience AT brechtbuhleduardr dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience AT bertollieduardo dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience AT dupratnetojoaop dermalsubstitutesuseinreconstructivesurgeryforskintumorsasinglecenterexperience |